Table 3 Comparison of symptomatic DVT incidence rate between seroconverted and non-converted patients
From: Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement
Seroconverted | Non-converted | Odds ratio | p-value | |
|---|---|---|---|---|
n = 36 | n = 68 | (95%CI) | ||
(%) | (%) | |||
DVT incidence | 11 (30.6%) | 5 (7.4%) | 5.5 (1.7–17.6%) | 0.028 |